Literature DB >> 19001446

Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.

Yasufumi Goto1, Takaaki Arigami, Minoru Kitago, Sandy L Nguyen, Norihiko Narita, Soldano Ferrone, Donald L Morton, Reiko F Irie, Dave S B Hoon.   

Abstract

Toll-like receptors (TLR) have been shown to be expressed on various types of cancers; however, their functional activity is not known. We examined TLR profiles of human melanoma cells and showed that TLR2, TLR3, and TLR4 were found to be highly expressed. By PCR array analysis, specific stimulation of TLR2, TLR3, and TLR4 on melanoma cells showed significant activation of the adaptor protein MyD88, as well as downstream signal transduction factors nuclear factor-kappaB and inflammatory response-related factors. Specific ligand activation of TLR2, TLR3, and TLR4 was shown to induce cell migration. Peripheral blood lymphocytes and melanoma purified RNA was shown to activate TLR3 on melanoma cells. These studies show expression and functional activity of specific TLRs on melanoma cells and as potential therapeutic targets to control tumor progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001446      PMCID: PMC3480738          DOI: 10.1158/1535-7163.MCT-08-0582

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  42 in total

Review 1.  Tumor necrosis factor or tumor promoting factor?

Authors:  Fran Balkwill
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

Review 2.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

3.  Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.

Authors:  Jie Fan; Asrar B Malik
Journal:  Nat Med       Date:  2003-02-18       Impact factor: 53.440

4.  Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .

Authors:  Zhengfan Jiang; Maryam Zamanian-Daryoush; Huiqing Nie; Aristobolo M Silva; Bryan R G Williams; Xiaoxia Li
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

5.  Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.

Authors:  Christine T Kuo; Dave S B Hoon; Hiroya Takeuchi; Roderick Turner; He-Jing Wang; Donald L Morton; Bret Taback
Journal:  J Clin Oncol       Date:  2003-08-11       Impact factor: 44.544

6.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Authors:  Enders K O Ng; Nancy B Y Tsui; Nicole Y L Lam; Rossa W K Chiu; Simon C H Yu; S C Cesar Wong; Elena S F Lo; Timothy H Rainer; Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

Review 7.  Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

Authors:  Peter W Szlosarek; Frances R Balkwill
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

8.  Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.

Authors:  Junji Uehori; Misako Matsumoto; Shoutaro Tsuji; Takashi Akazawa; Osamu Takeuchi; Shizuo Akira; Tsutomu Kawata; Ichiro Azuma; Kumao Toyoshima; Tsukasa Seya
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  52 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

Authors:  Richa Tewari; Saurav Roy Choudhury; Sadashib Ghosh; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2011-09-02       Impact factor: 4.599

Review 3.  Mechanisms and pathways of innate immune activation and regulation in health and cancer.

Authors:  Jun Cui; Yongjun Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

5.  TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10.

Authors:  Ileana S Mauldin; Ena Wang; Donna H Deacon; Walter C Olson; Yongde Bao; Craig L Slingluff
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

6.  Functional RET G691S polymorphism in cutaneous malignant melanoma.

Authors:  N Narita; A Tanemura; R Murali; R A Scolyer; S Huang; T Arigami; S Yanagita; K K Chong; J F Thompson; D L Morton; D S Hoon
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

7.  TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  Virology       Date:  2009-11-30       Impact factor: 3.616

8.  Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells.

Authors:  Jiong Jiang; Lei Dong; Bin Qin; Haitao Shi; Xiaoyan Guo; Yan Wang
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

9.  Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4.

Authors:  Ratika Srivastava; Degui Geng; Yingjia Liu; Liqin Zheng; Zhaoyang Li; Mary Ann Joseph; Colleen McKenna; Navneeta Bansal; Augusto Ochoa; Eduardo Davila
Journal:  Cancer Res       Date:  2012-10-04       Impact factor: 12.701

10.  Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

Authors:  Yusuke Sato; Yasufumi Goto; Norihiko Narita; Dave S B Hoon
Journal:  Cancer Microenviron       Date:  2009-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.